A phase I dose-escalation study of sibrotuzumab in patients with advanced or metastatic fibroblast activation protein-positive cancer

Andrew M. Scott, Greg Wiseman, Sydney Welt, Alex Adjei, Fook Thean Lee, Wendie Hopkins, Chaitan R. Divgi, Lorelei H. Hanson, Paul Mitchell, Denise N. Gansen, Steven M. Larson, James N. Ingle, Eric W. Hoffman, Paul Tanswell, Gerd Ritter, Leonard S. Cohen, Peter Bette, Lisa Arvay, Andree Amelsberg, Dan VlockWolfgang J. Rettig, Lloyd J. Old

Research output: Contribution to journal › Article › peer-review

256 Scopus citations

Fingerprint

Dive into the research topics of 'A phase I dose-escalation study of sibrotuzumab in patients with advanced or metastatic fibroblast activation protein-positive cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences